Moab Therapeutics is focused on developing minibinders, which are small, stable, and highly modular therapeutic agents. They leverage advanced AI models and a data generation platform to explore protein design space and create highly targeted binders.

Moab Therapeutics is focused on developing minibinders, which are small, stable, and highly modular therapeutic agents. They leverage advanced AI models and a data generation platform to explore protein design space and create highly targeted binders.